Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b.
Saved in:
| Title: | Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b. |
|---|---|
| Authors: | Suo S; Department of Haematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China., Fu RF; State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Qin A; PharmaEssentia Corporation, Taipei, Taiwan., Shao Z; The Second Hospital of Tianjin Medical University, Tianjin, China., Bai J; The Second Hospital of Tianjin Medical University, Tianjin, China., Zhou H; Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan, China., Xu N; Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China., Chen S; The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China., Zuo X; Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China., Du X; Shenzhen Second People's Hospital, Shenzhen, Guangdong, China., Duan M; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang L; The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Li P; Huashan Hospital of Fudan University, Shanghai, China., Zhang X; Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China., Zhang S; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wu D; PharmaEssentia Biotech (Beijing) Limited, Beijing, China., Zhang J; PharmaEssentia Biotech (Beijing) Limited, Beijing, China., Xiao Z; State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Zhang L; State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China., Jin J; Department of Haematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. |
| Source: | British journal of haematology [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2510-2514. Date of Electronic Publication: 2024 Oct 27. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39462216 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Suo+S%22">Suo S</searchLink>; Department of Haematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Fu+RF%22">Fu RF</searchLink>; State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Qin+A%22">Qin A</searchLink>; PharmaEssentia Corporation, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Shao+Z%22">Shao Z</searchLink>; The Second Hospital of Tianjin Medical University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Bai+J%22">Bai J</searchLink>; The Second Hospital of Tianjin Medical University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhou+H%22">Zhou H</searchLink>; Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan, China.<br /><searchLink fieldCode="AU" term="%22Xu+N%22">Xu N</searchLink>; Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Chen+S%22">Chen S</searchLink>; The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Zuo+X%22">Zuo X</searchLink>; Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China.<br /><searchLink fieldCode="AU" term="%22Du+X%22">Du X</searchLink>; Shenzhen Second People's Hospital, Shenzhen, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Duan+M%22">Duan M</searchLink>; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Li+P%22">Li P</searchLink>; Huashan Hospital of Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wu+D%22">Wu D</searchLink>; PharmaEssentia Biotech (Beijing) Limited, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; PharmaEssentia Biotech (Beijing) Limited, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Xiao+Z%22">Xiao Z</searchLink>; State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; State Key Laboratory of Experimental Haematology, National Clinical Research Center for Blood Diseases, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Jin+J%22">Jin J</searchLink>; Department of Haematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2510-2514. <i>Date of Electronic Publication: </i>2024 Oct 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39462216 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.19846 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2510 Titles: – TitleFull: Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa-2b. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Suo S – PersonEntity: Name: NameFull: Fu RF – PersonEntity: Name: NameFull: Qin A – PersonEntity: Name: NameFull: Shao Z – PersonEntity: Name: NameFull: Bai J – PersonEntity: Name: NameFull: Zhou H – PersonEntity: Name: NameFull: Xu N – PersonEntity: Name: NameFull: Chen S – PersonEntity: Name: NameFull: Zuo X – PersonEntity: Name: NameFull: Du X – PersonEntity: Name: NameFull: Duan M – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Li P – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Zhang S – PersonEntity: Name: NameFull: Wu D – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Xiao Z – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Jin J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2024 Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 205 – Type: issue Value: 6 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |